Key result
Arterial hypertension management faces ongoing challenges including high rates of uncontrolled blood pressure, underdiagnosis of secondary causes like primary aldosteronism, and the need for personalized genomic approaches.
This grand challenge article outlines key future directions in hypertension research and management, emphasizing resistant hypertension, secondary causes like primary aldosteronism, and the potential of pharmacogenomics.
Persistent gaps in BP control and aldosteronism detection warrant heightened clinical vigilance; leaves open optimal integration of pharmacogenomics into practice.
No takes yet. Share an insight, caveat, or question.
Gian Paolo Rossi (2015) conducted a review in Arterial hypertension. Arterial hypertension management faces ongoing challenges including high rates of uncontrolled blood pressure, underdiagnosis of secondary causes like primary aldosteronism, and the need for personalized genomic approaches.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: